FFRangio System vs RTHawk
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent rather than direct competitors, as they address different aspects of cardiac diagnostics and intervention. The FFRangio System focuses on providing wire-free FFR guidance for optimizing PCI decisions in coronary artery disease using angiography. In contrast, RTHawk streamlines cardiac MRI acquisition and offers advanced analysis for improved diagnostic efficiency.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
The FFRangio System is designed to provide wire-free and drug-free 3D FFR guidance for optimizing PCI decisions in patients with coronary artery disease. RTHawk, on the other hand, is an AI-driven software that simplifies and accelerates cardiac MRI acquisition and analysis for enhanced diagnostics across a broader range of cardiac conditions.
The FFRangio System utilizes AI to aid in quick angiogram analysis, generate a 3D model of the coronary tree from routine angiograms, and provide real-time FFRangio values and advanced insights. RTHawk employs AI for assisted MRI acquisition, one-click automation of standard cardiac views, artifact detection, and optimization of inversion time.
The FFRangio System provides real-time FFRangio values at every point on the coronary tree, simulated pullback curves to differentiate functional patterns of CAD, a Lesion Impact feature to assess residual ischemia, and an integrated sizing tool for non-invasive lesion measurements. RTHawk offers automated standard cardiac views, 4D flow measurements, and preliminary measures of left ventricular function, including ejection fraction, volumes, and mass.
The FFRangio System is ISO 27001 certified for information security, and a Business Associate Agreement (BAA) is likely, as it handles PHI. RTHawk explicitly states it is HIPAA compliant and has a BAA.
Yes, both the CathWorks FFRangio System and the HeartVista Cardiac Package, featuring RTHawk, have received FDA 510(k) clearance for clinical use.